ALBUMEDIX LTD

ALBIX

Line 33, in the field of development of medicines and pharmaceutical products should be inserted after cells in class 42.;Pharmaceutical products and substances; reagents * for pharmaceutical and medical use * ; diagnostic reagents * for medical use * ; proteins * for pharmaceutical and medical use * ; albumin * for pharmaceutical and medical use * ; recombinant albumin * for pharmaceutical and medical use * ; diagnostic imaging agents;In the Statement, Page 1, lines 5 - 11, Chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, namely, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, namely, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, namely, proteins for industrial use; should be deleted, and, In the Statement, Page 1, lines 15-17, ; chemical substances for use in tissue culture, namely, cell growth media for growing animal cells, stem cells and cell therapy preparations should be deleted, and, In the Statement, Page 1, line 19, after reagents, for pharmaceutical and medical use should be inserted, and, In the Statement, Page 1, line 20 after REAGENTS, for medical use should be inserted, and, In the Statement, Page 1, line 20, after PROTEINS, for pharmaceutical and medical use should be inserted, and, In the Statement, Page 1, line 20, after ALBUMIN, for pharmaceutical and medical use should be inserted, and, In the Statement, Page 1, line 20, after, RECOMBINANT ALBUMIN, for pharmaceutical and medical use should be inserted, and, In the Statement, Page 2, line 1, after ALL RELATING TO, the use of albumin in should be inserted.;[ Chemicals used in industry, science, agriculture, horticulture and forestry except herbicides, fungicides, parasiticides and insecticides; chemicals for use in medicines and in the preparation of pharmaceuticals, namely, excipients for the stabilisation of pharmaceuticals and vaccines; reagents, namely, medium ingredient for the growth of animal cell lines; diagnostic reagents for biochemical analysis; proteins, namely, proteins for industrial use; ] albumin for use in the manufacture of pharmaceuticals, vaccines, medical substances and cell therapy preparations; chemical substances for use in diagnostic kits, namely, albumin blocking agents used to bind to test kit surfaces to prevent non-specific binding of test substances to the surface [ ; chemical substances for use in tissue culture, namely, cell growth media for growing animal cells, stem cells and cell therapy preparations ];Scientific and technological research and development services for new products and uses in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; consultancy services regarding product research and product development in the fields of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cell research; advisory services with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies and stem cells; providing expert analysis with respect to research, development and suitable uses of biopharmaceuticals, pharmaceuticals, vaccines, medical devices, cell therapies, and stem cells * in the field of development of medicines and pharmaceutical products *; and scientific development and analysis in the fields of pharmaceuticals, vaccines, and drug discoveries; all relating to * the use of albumin in * science, biotechnology, biochemistry, biology, medicine and pharmaceuticals;

ALBIX

Pharmaceutical products and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; reagents and diagnostic reagents for medical use; protein supplements; albuminous preparations for pharmaceutical and medical purposes; recombinant albumin preparations for pharmaceutical and medical purposes; diagnostic radiopharmaceutical agent for use in PET imaging;Albumin for industrial purposes used for preparation of pharmaceuticals; reagents and diagnostic reagents for scientific and research use; protein for industrial use;Scientific and product research and development services; consultancy services in the field of scientific and product research and development services;

ALBUMEDIX

In the Statement, class 5 has been corrected per the Restriction dated January 17, 2019, and the Fnote dated January 26, 2019.;Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for pharmaceutical medicinal use; diagnostic reagents for medical use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin sold as an integral component of a vaccine and pharmaceuticals for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic agents for medical imaging [ ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient ];In the Statement, class 5 has been corrected per the Restriction and the Fnote dated January 22, 2021.;Chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents;Research and development services relating to pharmaceutical products;

ALBUMEDIX

The mark consists of the wording ALBUMEDIX in black below a design of a stylized red hexagon with curved edges. The hexagon design has a portion of its center and its bottom left edge removed and in white.;In the Statement Class 5 has been updated in accordance with the F-note dated 11/20/2020.;Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for medical use and pharmaceutical medicinal use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin for pharmaceutical and medical purposes; diagnostic agents for medical imaging * ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient *;In the statement, Class 5, has been updated in accordance with the F-note dated 2/3/2021.;The color(s) red, black and white is/are claimed as a feature of the mark.;Chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents;Research and development services relating to pharmaceutical products; consultation in the field of development of medicines and pharmaceuticals as well as analysis and development services in the nature of pharmaceutical research and development services;